BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24442582)

  • 1. SAPTA: a new design tool for improving TALE nuclease activity.
    Lin Y; Fine EJ; Zheng Z; Antico CJ; Voit RA; Porteus MH; Cradick TJ; Bao G
    Nucleic Acids Res; 2014 Apr; 42(6):e47. PubMed ID: 24442582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing and testing the activities of TAL effector nucleases.
    Lin Y; Cradick TJ; Bao G
    Methods Mol Biol; 2014; 1114():203-19. PubMed ID: 24557905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mojo Hand, a TALEN design tool for genome editing applications.
    Neff KL; Argue DP; Ma AC; Lee HB; Clark KJ; Ekker SC
    BMC Bioinformatics; 2013 Jan; 14():1. PubMed ID: 23323762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-TALEN: a web tool to design TALENs for genome engineering.
    Heigwer F; Kerr G; Walther N; Glaeser K; Pelz O; Breinig M; Boutros M
    Nucleic Acids Res; 2013 Nov; 41(20):e190. PubMed ID: 24003033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues.
    Christian ML; Demorest ZL; Starker CG; Osborn MJ; Nyquist MD; Zhang Y; Carlson DF; Bradley P; Bogdanove AJ; Voytas DF
    PLoS One; 2012; 7(9):e45383. PubMed ID: 23028976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction.
    Doyle EL; Booher NJ; Standage DS; Voytas DF; Brendel VP; Vandyk JK; Bogdanove AJ
    Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W117-22. PubMed ID: 22693217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.
    Cermak T; Doyle EL; Christian M; Wang L; Zhang Y; Schmidt C; Baller JA; Somia NV; Bogdanove AJ; Voytas DF
    Nucleic Acids Res; 2011 Jul; 39(12):e82. PubMed ID: 21493687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
    Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T
    Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity.
    Guilinger JP; Pattanayak V; Reyon D; Tsai SQ; Sander JD; Joung JK; Liu DR
    Nat Methods; 2014 Apr; 11(4):429-35. PubMed ID: 24531420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing.
    Sun N; Zhao H
    Biotechnol Bioeng; 2013 Jul; 110(7):1811-21. PubMed ID: 23508559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity.
    Sakuma T; Ochiai H; Kaneko T; Mashimo T; Tokumasu D; Sakane Y; Suzuki K; Miyamoto T; Sakamoto N; Matsuura S; Yamamoto T
    Sci Rep; 2013 Nov; 3():3379. PubMed ID: 24287550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering customized TALE nucleases (TALENs) and TALE transcription factors by fast ligation-based automatable solid-phase high-throughput (FLASH) assembly.
    Reyon D; Maeder ML; Khayter C; Tsai SQ; Foley JE; Sander JD; Joung JK
    Curr Protoc Mol Biol; 2013 Jul; Chapter 12():Unit 12.16. PubMed ID: 23821439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-RVD mutations that enhance the dynamics of the TAL repeat array along the superhelical axis improve TALEN genome editing efficacy.
    Tochio N; Umehara K; Uewaki JI; Flechsig H; Kondo M; Dewa T; Sakuma T; Yamamoto T; Saitoh T; Togashi Y; Tate SI
    Sci Rep; 2016 Nov; 6():37887. PubMed ID: 27883072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A One-Step System for Convenient and Flexible Assembly of Transcription Activator-Like Effector Nucleases (TALENs).
    Zhao J; Sun W; Liang J; Jiang J; Wu Z
    Mol Cells; 2016 Sep; 39(9):687-91. PubMed ID: 27604899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted gene disruption in the Xenopus tropicalis genome using designed TALE nucleases.
    Nakajima K; Nakai Y; Okada M; Yaoita Y
    Zoolog Sci; 2013 Jun; 30(6):455-60. PubMed ID: 23721469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid assembly of customized TALENs into multiple delivery systems.
    Zhang Z; Zhang S; Huang X; Orwig KE; Sheng Y
    PLoS One; 2013; 8(11):e80281. PubMed ID: 24244669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4 (Tlr4) knockout rats produced by transcriptional activator-like effector nuclease (TALEN)-mediated gene inactivation.
    Ferguson C; McKay M; Harris RA; Homanics GE
    Alcohol; 2013 Dec; 47(8):595-9. PubMed ID: 24199847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directed evolution of the TALE N-terminal domain for recognition of all 5' bases.
    Lamb BM; Mercer AC; Barbas CF
    Nucleic Acids Res; 2013 Nov; 41(21):9779-85. PubMed ID: 23980031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully Automated One-Step Synthesis of Single-Transcript TALEN Pairs Using a Biological Foundry.
    Chao R; Liang J; Tasan I; Si T; Ju L; Zhao H
    ACS Synth Biol; 2017 Apr; 6(4):678-685. PubMed ID: 28103009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage.
    Fine EJ; Cradick TJ; Zhao CL; Lin Y; Bao G
    Nucleic Acids Res; 2014 Apr; 42(6):e42. PubMed ID: 24381193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.